您好，欢迎来到化工原料网！ [登录] [免费注册]
化工原料网
发布求购
位置：首页 > 产品库 > Larazotide
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Larazotide
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Larazotide图片
CAS NO:258818-34-7
包装与价格：
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Larazotideis 是一种多肽，是具有口服活性的zonulin拮抗剂。Larazotide 对水痘带状疱疹病毒(VZV)具有抗病毒活性，对 OKA 和 07-1 株系的EC50值分别为 44.14 和 59.06 μM。Larazotide 可用于乳糜泻和感染的研究。
生物活性

Larazotideis a peptide which is an orally activezonulinantagonist. Larazotide shows antiviral activity to varicella-zoster virus(VZV)withEC50sof 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide can be used for the research of celiac disease andinfection[1][2].

体外研究
(In Vitro)

Larazotide (1-100 μM; 5 d) affects Vero cell growth[1].
Larazotide (1-100 μM; 3 d) shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively[1].
Larazotide (1 and 3 mM; 72 h) inhibits cytokine-induced tight junction permeability in Caco-2 cells[2].
Larazotide (100 μM; 3 h) inhibits gliadin translocation across Caco-2 monolayers[2].
Larazotide (12.5 mM; 1 h) inhibits PTG-induced ZO-1 redistribution and actin cytoskeletal rearrangement in IEC6 cells[2].

Cell Cytotoxicity Assay[1]

Cell Line:Vero cell line
Concentration:1-100 μM
Incubation Time:5 days
Result:Inhibited Vero cell growth with an CC50value of 82.5 μM.
体内研究
(In Vivo)

Larazotide (250 μg; i.p. twice a week for 7 weeks) inhibits intestinal permeability in gluten-sensitive transgenic mice[1].

Animal Model:HLA-HCD4/DQ8 double transgenic mice[2]
Dosage:250 μg
Administration:Intraperitoneal injection; 250 μg twice a week for 7 weeks
Result:Improved barrier function parameters and reduced macrophage counts in the lamina propria to control levels.
Clinical Trial
分子量

725.83

Formula

C32H55N9O10

CAS 号

258818-34-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.